Security key
761330109
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 67,635,567
- Total 13F value
- $1,824,203,436
- Share change
- +11,589,560
- Put/Call ratio
- 39%
- SEC-reported price per share
- $27.00
- Number of holders
- 178
- Value change
- +$329,402,349
- Number of buys
- 111
- Number of sells
- 58
- Shares outstanding
- 104,661,494
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
178
Top holders
10
RVNC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Revance Therapeutics, Inc. SEC filings
Revance Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 761330109
Recent filing periods:
Ownership snapshot
Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JPMORGAN CHASE & CO
Disclosed value leader
JPMORGAN CHASE & CO
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 6.4%
Showing 1-6 of 15 holder rows.
Quick read
JPMORGAN CHASE & CO leads the comparable SEC ownership view at 6.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JPMORGAN CHASE & CO's linked filing trail.
Comparable ownership
Top 5
JPMORGAN CHASE & CO
6.4%
BlackRock Finance, Inc.
5.4%
Capital World Investors
4.4%
Palo Alto Investors LP
4.2%
VANGUARD GROUP INC
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
Company
|
6.4%
|
$92,427,000
6,687,925 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
5.4%
|
$78,564,000
5,684,831 shares
|
— | 30 Jun 2022 |
| Capital World Investors |
13F
Company
|
4.4%
|
$63,434,000
4,590,000 shares
|
— | 30 Jun 2022 |
| Palo Alto Investors LP |
13F
Company
|
4.2%
|
$60,878,000
4,405,039 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
3.5%
|
$51,176,000
3,703,055 shares
|
— | 30 Jun 2022 |
| Polar Capital Holdings Plc |
13F
Company
|
3%
|
$43,078,000
3,117,052 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
178
Shares
67,635,567
Rows available
178
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
156
Q3 2022 holders
178
Holder diff
22
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend